| 臺大學術典藏 |
2021-02-02T09:21:43Z |
A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer
|
Schmid, Peter; Sablin, Marie Paule; Bergh, Jonas; Im, Seock Ah; Yen-Shen Lu; Martínez, Noelia; Neven, Patrick; Lee, Keun Seok; Morales, Serafín; Pérez-Fidalgo, J. Alejandro; Adamson, Douglas; Gonçalves, Anthony; Prat, Aleix; Jerusalem, Guy; Schlieker, Laura; Espadero, Rosa Maria; Bogenrieder, Thomas; Huang, Dennis Chin Lun; Crown, John; Cortés, Javier |
| 臺大學術典藏 |
2020-05-25T06:52:11Z |
Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-na?ve patients with locally advanced or metastatic breast carcinoma
|
Cheng A.-L.;Chang K.-J;Chen M.M;Bu C.-F;Yen-Shen Lu;Chao T.-Y;Huang C.-S;Hsu C; Hsu C; Huang C.-S; Chao T.-Y; YEN-SHEN LU; Bu C.-F; Chen M.M; Chang K.-J; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:11Z |
A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil
|
Hsu C; Yang C.-H; YEN-SHEN LU; Lin C.-C; Bu C.-F; Yeh K.-H.; Yeh K.-H.;Bu C.-F;Lin C.-C;Yen-Shen Lu;Yang C.-H;Hsu C;Cheng A.-L;Hsu C.-H; Hsu C.-H; Cheng A.-L |
| 臺大學術典藏 |
2020-05-25T06:52:11Z |
Basal levels and patterns of anticancer drug-induced activation of nuclear factor-�eB (NF-�eB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells
|
Cheng A.-L.;Gao M;Liao C.-M;Lai G.-M;Yen-Shen Lu;Yeh P.-Y;Chuang S.-E; Chuang S.-E; Yeh P.-Y; YEN-SHEN LU; Lai G.-M; Liao C.-M; Gao M; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:11Z |
MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer
|
Tripathy D; Rugo H; Park J; Hwang S; Kuerer H; Sudilovsky D; YEN-SHEN LU; Hylton N.; Partridge S; Kaplan E; Hylton N.;Yen-Shen Lu;Sudilovsky D;Kuerer H;Hwang S;Park J;Rugo H;Tripathy D;Partridge S;Kaplan E;Esserman L; Esserman L |
| 臺大學術典藏 |
2020-05-25T06:52:10Z |
Recent advances in the management of primary breast cancers
|
Huang C.-S.;Kuo S.-H;Yen-Shen Lu; YEN-SHEN LU; Kuo S.-H; Huang C.-S. |
| 臺大學術典藏 |
2020-05-25T06:52:10Z |
Phase II study of combination doxorubicin, interferon-�\, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma
|
Cheng A.-L.;Wu C.-Y;Hsu C.-H;Yang C.-H;Yeh K.-H;Kuo S.-H;Li C.-C;Hsu C;Yen-Shen Lu; YEN-SHEN LU; Hsu C; Li C.-C; Kuo S.-H; Yeh K.-H; Yang C.-H; Hsu C.-H; Wu C.-Y; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:10Z |
High-dose Tamoxifen Modulates Drug Resistance to Doxorubicin, Dacarbazine and Ifosfamide in Metastatic Uterine Leiomyosarcoma
|
Cheng A.-L.;Hsiao C.-H;Yen-Shen Lu;Yeh K.-H; Yeh K.-H; YEN-SHEN LU; Hsiao C.-H; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:10Z |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tract
|
Cheng A.-L.;Wu C.-Y;Chen J.-S;Li C.-C;Liu H.-T;Hsu C.-H;Yen-Shen Lu;Yeh K.-H;Yang C.-H;Shen Y.-C;Hsu C; Hsu C; Shen Y.-C; Yang C.-H; Yeh K.-H; YEN-SHEN LU; Hsu C.-H; Liu H.-T; Li C.-C; Chen J.-S; Wu C.-Y; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:09Z |
Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer
|
Yeh K.-H;Yen-Shen Lu;Hsu C.-H;Lin J.-F;Hsu C;Kuo S.-H;Li Jr. S;Cheng A.-L.; Yeh K.-H; YEN-SHEN LU; Hsu C.-H; Lin J.-F; Hsu C; Kuo S.-H; Li Jr. S; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:09Z |
Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer
|
Yeh K.H;Yen-Shen Lu;Hsu C.H;Lin J.F;Chao H.J;Huang T.C;Chung C.Y;Chang C.S;Yang C.H;Cheng A.L.; Yeh K.H; YEN-SHEN LU; Hsu C.H; Lin J.F; Chao H.J; Huang T.C; Chung C.Y; Chang C.S; Yang C.H; Cheng A.L. |
| 臺大學術典藏 |
2020-05-25T06:52:09Z |
Angiogenic response of locally advanced breast cancer to neoadjuvant chemotherapy evaluated with parametric histogram from dynamic contrast-enhanced MRI
|
Tseng W.-Y.I.;Yen-Shen Lu;Chen J.-H;Liu Y.-J;Huang C.-S;Chang Y.-C; Chang Y.-C; Huang C.-S; Liu Y.-J; Chen J.-H; YEN-SHEN LU; Tseng W.-Y.I. |
| 臺大學術典藏 |
2020-05-25T06:52:08Z |
Glucocorticoids enhance cytotoxicity of cisplatin via suppression of NF-�eB activation in the glucocorticoid receptor-rich human cervical carcinoma cell line SiHa
|
Yen-Shen Lu;Yeh P.-Y;Chuang S.-E;Gao M;Kuo M.-L;Cheng A.-L.; YEN-SHEN LU; Yeh P.-Y; Chuang S.-E; Gao M; Kuo M.-L; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:08Z |
Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer
|
Ch'Ang H.-J;Wang C.-C;Cheng A.-L;Hsu C;Yen-Shen Lu;Chang M.-C;Lin J.-T;Wang H.-P;Shiah H.-S;Liu T.-W;Chang J.-Y;Whang-Peng J;Chen L.-T.; Ch'ang H.-J; Wang C.-C; Cheng A.-L; Hsu C; YEN-SHEN LU; Chang M.-C; Lin J.-T; Wang H.-P; Shiah H.-S; Liu T.-W; Chang J.-Y; Whang-Peng J; Chen L.-T. |
| 臺大學術典藏 |
2020-05-25T06:52:08Z |
Effects of glucocorticoids on the growth and chemosensitivity of carcinoma cells are heterogeneous and require high concentration of functional glucocorticoid receptors
|
Kuo M.-L; Kuo S.-H; Cheng A.-L.; Yeh K.-H; Yeh P.-Y; Lien H.-C; YEN-SHEN LU; Yen-Shen Lu;Lien H.-C;Yeh P.-Y;Yeh K.-H;Kuo M.-L;Kuo S.-H;Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:08Z |
Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients
|
Su W.-P;Wen C.-C;Hsiung C.A;Su I.-J;Cheng A.-L;Chang M.-C;Tsao C.-J;Kao W.-Y;Uen W.-C;Hsu C.-H;Yen-Shen Lu;Tien H.-F;Chao T.-Y;Chen L.-T;Whang-Peng J;Chen P.-J.; Su W.-P; Wen C.-C; Hsiung C.A; Su I.-J; Cheng A.-L; Chang M.-C; Tsao C.-J; Kao W.-Y; Uen W.-C; Hsu C.-H; YEN-SHEN LU; Tien H.-F; Chao T.-Y; Chen L.-T; Whang-Peng J; Chen P.-J. |
| 臺大學術典藏 |
2020-05-25T06:52:07Z |
Efficacy of a novel histone deacetylase inhibitor in murine models of hepatocellular carcinoma
|
Wang Y.-C; Wang D; Hung J.-H; Tang M; Lin Z.-Z; Chen T.-J; Cheng A.-L; Chen C.-S.; Yen-Shen Lu;Kashida Y;Kulp S.K;Wang Y.-C;Wang D;Hung J.-H;Tang M;Lin Z.-Z;Chen T.-J;Cheng A.-L;Chen C.-S.; YEN-SHEN LU; Kashida Y; Kulp S.K |
| 臺大學術典藏 |
2020-05-25T06:52:07Z |
Glucocorticoid receptor expression in advanced non-small cell lung cancer: clinicopathological correlation and in vitro effect of glucocorticoid on cell growth and chemosensitivity
|
Yen-Shen Lu;Lien H.-C;Yeh P.-Y;Kuo S.-H;Chang W.-C;Kuo M.-L;Cheng A.-L.; YEN-SHEN LU; Lien H.-C; Yeh P.-Y; Kuo S.-H; Chang W.-C; Kuo M.-L; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:07Z |
Differential expression of glucocorticoid receptor in human breast tissues and related neoplasms
|
Lien H.-C;Yen-Shen Lu;Cheng A.-L;Chang W.-C;Jeng Y.-M;Kuo Y.-H;Huang C.-S;Chang K.-J;Yao Y.-T.; Lien H.-C; YEN-SHEN LU; Cheng A.-L; Chang W.-C; Jeng Y.-M; Kuo Y.-H; Huang C.-S; Chang K.-J; Yao Y.-T. |
| 臺大學術典藏 |
2020-05-25T06:52:07Z |
A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer
|
Lin C.-C;Cheng A.-L;Hsu C.-H;Yen-Shen Lu;Hsu C;Yeh K.-H;Wu C.-Y;Huang C.-S;Yang C.-H.; Lin C.-C; Cheng A.-L; Hsu C.-H; YEN-SHEN LU; Hsu C; Yeh K.-H; Wu C.-Y; Huang C.-S; Yang C.-H. |
| 臺大學術典藏 |
2020-05-25T06:52:06Z |
Differential expression of glucocorticoid receptor in carcinomas of the human digestive system
|
Cheng A.-L.;Chang W.-C;Yao Y.-T;Shun C.-T;Yen-Shen Lu;Lien H.-C; Lien H.-C; YEN-SHEN LU; Shun C.-T; Yao Y.-T; Chang W.-C; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:06Z |
Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylation
|
Chen C.-S; Wang Y.-C; Yang H.-C; Huang P.-H; Kulp S.K; Yang C.-C; Yen-Shen Lu; Matsuyama S; Chen C.-Y; Chen C.-S. |
| 臺大學術典藏 |
2020-05-25T06:52:06Z |
Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylation
|
Chen C.-S;Wang Y.-C;Yang H.-C;Huang P.-H;Kulp S.K;Yang C.-C;Yen-Shen Lu;Matsuyama S;Chen C.-Y;Chen C.-S.; Chen C.-S; Wang Y.-C; Yang H.-C; Huang P.-H; Kulp S.K; Yang C.-C; YEN-SHEN LU; Matsuyama S; Chen C.-Y; Chen C.-S. |
| 臺大學術典藏 |
2020-05-25T06:52:06Z |
Pneumatosis coli after etoposide chemotherapy for breast cancer
|
Shih I.-L;Yen-Shen Lu;Wang H.-P;Liu K.-L.; Shih I.-L; YEN-SHEN LU; Wang H.-P; Liu K.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:06Z |
Dose variation and regimen modification of adjuvant chemotherapy in daily practice affect survival of stage I-II and operable stage III Taiwanese breast cancer patients
|
Huang C.-S.;Chen T.-Z;Lin C.-H;Yen-Shen Lu;You S.-L;Lien H.-C;Kuo S.-H; Kuo S.-H; Lien H.-C; You S.-L; YEN-SHEN LU; Lin C.-H; Chen T.-Z; Huang C.-S. |
